Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

FBRX holding history

Forte Biosciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FBRX overviewAll 13F holders of FBRXFull Q2 2026 holdings

Shares (Q2 2026)
45,007
Value
$956.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of FBRX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202645,007$956.4K<0.1%−455,291−91.0%ReducedHolders
Q1 2026500,298$13.0M<0.1%+429,767+609.3%AddedHolders
Q4 202570,531$1.92M<0.1%+70,380+46,609.3%AddedHolders
Q3 2025151$2.27K<0.1%00.0%UnchangedHolders
Q2 2025151$1.95K<0.1%00.0%UnchangedHolders
Q1 2025151$1.17K<0.1%00.0%UnchangedHolders
Q4 2024151$3.43K<0.1%00.0%UnchangedHolders
Q3 2024151$844<0.1%−1−0.8%ReducedConverted for a 1-for-25 splitHolders
Q2 20243,804$2.04K<0.1%+2,810+282.7%AddedHolders
Q1 2024994$692<0.1%00.0%UnchangedHolders
Q4 2023994$817<0.1%00.0%UnchangedHolders
Q3 2023994$658<0.1%00.0%UnchangedHolders
Q2 2023994$1.03K<0.1%−112−10.1%ReducedHolders
Q1 20231,106$1.12K<0.1%−313−22.1%ReducedHolders
Q4 20221,419$1.42K<0.1%+14+1.0%AddedHolders
Q3 20221,405$1.00K<0.1%−335,634−99.6%ReducedHolders
Q2 2022337,039$438.0K<0.1%−100,161−22.9%ReducedHolders
Q1 2022437,200$637.0K<0.1%−674,153−60.7%ReducedHolders
Q4 20211,111,353$2.38M<0.1%+1,101,718+11,434.5%AddedHolders
Q3 20219,635$28.0K<0.1%−25,383−72.5%ReducedHolders
Q2 202135,018$1.18M<0.1%+24,340+227.9%AddedHolders
Q1 202110,678$366.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.